The Arizona Commerce Authority (ACA) has announced the 25 semifinalists that will move on in the Fall 2012 Arizona Innovation Challenge (AIC). Winners are expected to be announced in December 2012.Continue reading
Category Archives: AZBio News
The Day After – Updates on the 2012 Election
2012 marked one of the most media heavy campaigns on record. From TV to radio and email to Facebook and Twitter,the info flowed in. We all were greeted with full mailboxs at home each evening. Now that the votes are in, here is your post election update.Continue reading
UA Steele Center Receives $1.65M to Continue Autoimmune Disease Research
The UA Steele Children’s Research Center study seeks to decipher how the sodium-hydrogen transporter NHE3 contributes to the health of the gastrointestinal tract.Continue reading
Opportunity Alert: Moving from Preclinical to Clinical
FierceBiotech offering a free eBook on moving along the path from Preclinical to ClinicalContinue reading
UA Cancer Center awarded $9.6 million for prevention agent studies
TUCSON, Ariz. – The University of Arizona Early Phase Chemoprevention Consortium led by UA Cancer Center researchers Sherry Chow, PhD, and David Alberts, MD, has been awarded funding by the National Cancer Institute to conduct early-phase clinical trials to evaluate the safety, clinical activity, and biological effects of novel cancer preventive agents. This five-year award will total up to $9.6 million.Continue reading
Opportunity Alert: ACA Program Helps You Submit SBIR STTR Grants
The Arizona Commerce Authority was awarded an $80,000 grant from the US Small Business Administration and has contributed $200,000 in matching funds and in-kind services to develop the PIII Playbook; a structured program of training and technical assistance to prepare Arizona’s small high-tech companies to compete more effectively for federal SBIR/STTR Phase I and II awards and ultimately commercialize their innovations in Phase III.
UA’s Dr. Eric P. Gall Honored with 2012 Arthritis Foundation’s ‘Freedom of Movement Award’
Interim director and one of the founders of The University of Arizona Arthritis Center recognized for his long association and many leadership roles with the organization.Continue reading
TESARO and Virginia G. Piper Cancer Center announce enrollment of first patient in clinical trial of TSR-011
Company plans to expand Phase 1/2 clinical trial of the Anaplastic Lymphoma Kinase (ALK) Inhibitor, TSR-011, to multiple clinical trial sitesContinue reading
1st Total Artificial Heart Patient Discharged from Ege University in Turkey
Former Professional Soccer Player Waits for Donor Heart at Home Using the Freedom® Portable Driver to Power His Total Artificial HeartContinue reading
BIOACCEL RECEIVES NATIONAL AWARD RECOGNITION FOR IMPROVING REGIONAL ECONOMIES THROUGH SCIENCE, TECHNOLOGY AND INNOVATION
Awards were presented during SSTI’s 16th Annual Conference in AtlantaContinue reading